These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 33025002)
1. Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age. Prentice RL; Aragaki AK; Chlebowski RT; Rossouw JE; Anderson GL; Stefanick ML; Wactawski-Wende J; Kuller LH; Wallace R; Johnson KC; Shadyab AH; Gass M; Manson JE Am J Epidemiol; 2021 Feb; 190(3):365-375. PubMed ID: 33025002 [TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921 [TBL] [Abstract][Full Text] [Related]
3. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J; JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397 [TBL] [Abstract][Full Text] [Related]
4. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S; JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697 [TBL] [Abstract][Full Text] [Related]
5. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. LaCroix AZ; Chlebowski RT; Manson JE; Aragaki AK; Johnson KC; Martin L; Margolis KL; Stefanick ML; Brzyski R; Curb JD; Howard BV; Lewis CE; Wactawski-Wende J; JAMA; 2011 Apr; 305(13):1305-14. PubMed ID: 21467283 [TBL] [Abstract][Full Text] [Related]
6. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Prentice RL; Manson JE; Langer RD; Anderson GL; Pettinger M; Jackson RD; Johnson KC; Kuller LH; Lane DS; Wactawski-Wende J; Brzyski R; Allison M; Ockene J; Sarto G; Rossouw JE Am J Epidemiol; 2009 Jul; 170(1):12-23. PubMed ID: 19468079 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051 [TBL] [Abstract][Full Text] [Related]
8. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. Heiss G; Wallace R; Anderson GL; Aragaki A; Beresford SA; Brzyski R; Chlebowski RT; Gass M; LaCroix A; Manson JE; Prentice RL; Rossouw J; Stefanick ML; JAMA; 2008 Mar; 299(9):1036-45. PubMed ID: 18319414 [TBL] [Abstract][Full Text] [Related]
9. Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. Aedo S; Cavada G; Blümel JE; Chedraui P; Fica J; Barriga P; Brantes S; Irribarra C; Vallejo M; Campodónico Í Menopause; 2015 Dec; 22(12):1317-22. PubMed ID: 25968833 [TBL] [Abstract][Full Text] [Related]
10. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB; JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707 [TBL] [Abstract][Full Text] [Related]
11. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007 [TBL] [Abstract][Full Text] [Related]
12. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. Chlebowski RT; Rohan TE; Manson JE; Aragaki AK; Kaunitz A; Stefanick ML; Simon MS; Johnson KC; Wactawski-Wende J; O'Sullivan MJ; Adams-Campbell LL; Nassir R; Lessin LS; Prentice RL JAMA Oncol; 2015 Jun; 1(3):296-305. PubMed ID: 26181174 [TBL] [Abstract][Full Text] [Related]
13. Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial. Manson JE; Aragaki AK; Bassuk SS; Chlebowski RT; Anderson GL; Rossouw JE; Howard BV; Thomson CA; Stefanick ML; Kaunitz AM; Crandall CJ; Eaton CB; Henderson VW; Liu S; Luo J; Rohan T; Shadyab AH; Wells G; Wactawski-Wende J; Prentice RL; Ann Intern Med; 2019 Sep; 171(6):406-414. PubMed ID: 31499528 [TBL] [Abstract][Full Text] [Related]
14. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH; JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206 [TBL] [Abstract][Full Text] [Related]
15. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. Chlebowski RT; Anderson GL; Sarto GE; Haque R; Runowicz CD; Aragaki AK; Thomson CA; Howard BV; Wactawski-Wende J; Chen C; Rohan TE; Simon MS; Reed SD; Manson JE J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26668177 [TBL] [Abstract][Full Text] [Related]
16. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review. Manson JE; Crandall CJ; Rossouw JE; Chlebowski RT; Anderson GL; Stefanick ML; Aragaki AK; Cauley JA; Wells GL; LaCroix AZ; Thomson CA; Neuhouser ML; Van Horn L; Kooperberg C; Howard BV; Tinker LF; Wactawski-Wende J; Shumaker SA; Prentice RL JAMA; 2024 May; 331(20):1748-1760. PubMed ID: 38691368 [TBL] [Abstract][Full Text] [Related]
17. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677 [TBL] [Abstract][Full Text] [Related]
18. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D; JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863 [TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials. Maalouf NM; Sato AH; Welch BJ; Howard BV; Cochrane BB; Sakhaee K; Robbins JA Arch Intern Med; 2010 Oct; 170(18):1678-85. PubMed ID: 20937929 [TBL] [Abstract][Full Text] [Related]
20. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. Chlebowski RT; Hendrix SL; Langer RD; Stefanick ML; Gass M; Lane D; Rodabough RJ; Gilligan MA; Cyr MG; Thomson CA; Khandekar J; Petrovitch H; McTiernan A; JAMA; 2003 Jun; 289(24):3243-53. PubMed ID: 12824205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]